Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
about
Interplay Between Metabolism and Oncogenic Process: Role of microRNAsThe role of cancer stem cells and miRNAs in defining the complexities of brain metastasisThe miR-200 and miR-221/222 microRNA families: opposing effects on epithelial identityImpact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological CancerRegulating miRNA by natural agents as a new strategy for cancer treatmentClinical advances in molecular biomarkers for cancer diagnosis and therapyMicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential3, 3'-Diindolylmethane enhances the effectiveness of herceptin against HER-2/neu-expressing breast cancer cellsThe Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinomasiRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells.MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approachesSweating the small stuff: microRNAs and genetic changes define pancreatic cancer.Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasisRegulation of the mRNA half-life in breast cancerMiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN.Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cellsMetabolic reprogramming and epithelial-to-mesenchymal transition in cancer.MicroRNA-200a regulates Grb2 and suppresses differentiation of mouse embryonic stem cells into endoderm and mesoderm.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F.Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer.The role of microRNAs in breast cancer migration, invasion and metastasisRe-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer.The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.Innovative therapeutic strategies in the treatment of brain metastases.Pathways to breast cancer recurrence.Novel strategies targeting cancer stem cells through phytochemicals and their analogsGarcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells.miR-200b and cancer/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs.Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapyWASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invasiveness in breast cancer cellsExpression of microRNAs: potential molecular link between obesity, diabetes and cancer.Recent updates on the role of microRNAs in prostate cancer.Regulation of Aerobic Glycolysis by microRNAs in Cancer.MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications.
P2860
Q26770381-BBCA044F-FEB6-4BD2-8212-BCB725CFAA93Q26864372-E4149C95-019A-4389-9CEC-E2364EDBFE33Q27010233-C3683676-6114-4CAD-AA94-2723EB733FE9Q27016123-40CE4EAB-3731-4A1B-BB96-4FBC40DEDAF0Q27026972-23223F52-C8CA-49DB-A0D9-FDAAD966EE52Q27027560-2BBC1615-4F85-4E6E-AB89-900C75197D6CQ28081081-EF531CAC-1C5B-450F-8B4A-68A2F58655EAQ28485231-72E6ACEB-0327-494E-980F-F2311D2C9D72Q28540190-F89CBC08-EB4B-446A-9F9E-AFD70DC392C3Q33685802-9210CCFA-946D-433F-B319-30700932E007Q33823829-8008389F-B54D-4F71-9E1B-BB0386AFD747Q33835913-165B9EAF-097C-4CEE-AC86-056AE7D15D6BQ33862088-15678AFD-89F8-4697-8CD0-A079E87DB178Q33961973-449DCA17-14B8-4D6C-BB83-06E45AE903F2Q34023658-BC127D9E-0DB6-456A-B323-20AC9FCFA7CCQ34179919-2983B064-F85A-451A-931E-FC385E09EF3EQ34533633-E9E644D2-7EBA-4D08-BB6C-6415889598A1Q34555855-4092C57B-BDB5-4DD3-B286-26D74B8F99B3Q34852344-F5758C19-4450-4F08-9896-F2FA4127062CQ35094742-303F0B28-3A1C-475F-8F67-181EDFF19A20Q35562532-099F2BFD-940C-4985-B264-5573EFE8096DQ35697850-03A99031-EEF2-488B-9E31-DD5050A0BE25Q35709636-F1BA3938-8733-4BE0-A6DB-6BA675D4AB76Q36191985-EECC9C92-6BDA-4559-995E-0699170EE699Q36387904-62F4769B-D237-46CF-BACD-65363CFC822DQ36396579-82021D06-86C5-41EA-ADE2-6C03AA77C4D3Q36402024-6DADDAB1-7AE5-4F5F-8501-8037FDD2F1B8Q36413699-3AB369B5-2602-4187-8595-07EA45FD015AQ36446246-6E852303-4021-428C-A7A3-19627198D15BQ36590195-A6BBACFE-80BE-4DDA-9178-1D0289DB9DD7Q36702139-68A3F066-6056-4BB5-B959-C5CC15803198Q37198168-12E9112D-2EC8-429C-9A2E-B308DC1D7B16Q37330990-5AAE17FF-7A47-40AB-944B-A3B4B1960A78Q37405030-838F2E90-E000-4D01-9DFB-00EC2AA10A43Q37512204-CCE943BF-49D0-4112-8DF6-A90C483AE6CFQ37720633-99CA836E-EA05-4269-A9B3-FAE4161C2B71Q37902256-E7EAC013-AF76-45DF-8B6D-AAA95D667C69Q37993624-1BE5045F-A2F6-41F6-8C8E-B29128AA4454Q38026041-7D93C12F-C5AC-454A-8290-EFCAF60096D6Q38036917-F21F869D-97D8-4AEC-8C3C-D4423C766E00
P2860
Phosphoglucose isomerase/autocrine motility factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@ast
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@en
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@nl
type
label
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@ast
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@en
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@nl
prefLabel
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@ast
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@en
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@nl
P2093
P2860
P1433
P1476
Phosphoglucose isomerase/autoc ...... iR-200 in breast cancer cells.
@en
P2093
Aamir Ahmad
Amro Aboukameel
Avraham Raz
Dejuan Kong
Fazlul H Sarkar
Seema Sethi
Zhiwei Wang
P2860
P304
P356
10.1158/0008-5472.CAN-10-0965
P407
P577
2011-03-09T00:00:00Z